Are there Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, at-risk Individuals?

Milton E. Strauss, Jason Brandt

Research output: Contribution to journalArticle

Abstract

It has recently been reported that persons at risk for Huntington's disease who test positive for the linked restriction fragment length polymorphism on chromosome 4 display neuropsychologic impairments when compared with at-risk subjects who test negative for this marker. We have studied a substantially larger series of at-risk subjects who have been thoroughly screened for the absence of neurologic or psychiatric features of Huntington's disease and have undergone predictive DNA testing. No evidence of cognitive or emotional differences between markerpositive and marker-negative individuals was found. Consideration of the designs and findings of the two studies indicates that it is premature to conclude that there are neuropsychologic impairments in Huntington's disease that precede the clinical onset of the illness.

Original languageEnglish (US)
Pages (from-to)905-908
Number of pages4
JournalArchives of Neurology
Volume47
Issue number8
DOIs
StatePublished - 1990

Fingerprint

Huntington Disease
Genes
Chromosomes, Human, Pair 4
Restriction Fragment Length Polymorphisms
Nervous System
Psychiatry
DNA
Manifestation
Gene
Impairment

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Are there Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, at-risk Individuals? / Strauss, Milton E.; Brandt, Jason.

In: Archives of Neurology, Vol. 47, No. 8, 1990, p. 905-908.

Research output: Contribution to journalArticle

@article{27f975acaf72407591b268adfb4b649a,
title = "Are there Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, at-risk Individuals?",
abstract = "It has recently been reported that persons at risk for Huntington's disease who test positive for the linked restriction fragment length polymorphism on chromosome 4 display neuropsychologic impairments when compared with at-risk subjects who test negative for this marker. We have studied a substantially larger series of at-risk subjects who have been thoroughly screened for the absence of neurologic or psychiatric features of Huntington's disease and have undergone predictive DNA testing. No evidence of cognitive or emotional differences between markerpositive and marker-negative individuals was found. Consideration of the designs and findings of the two studies indicates that it is premature to conclude that there are neuropsychologic impairments in Huntington's disease that precede the clinical onset of the illness.",
author = "Strauss, {Milton E.} and Jason Brandt",
year = "1990",
doi = "10.1001/archneur.1990.00530080093016",
language = "English (US)",
volume = "47",
pages = "905--908",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Are there Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, at-risk Individuals?

AU - Strauss, Milton E.

AU - Brandt, Jason

PY - 1990

Y1 - 1990

N2 - It has recently been reported that persons at risk for Huntington's disease who test positive for the linked restriction fragment length polymorphism on chromosome 4 display neuropsychologic impairments when compared with at-risk subjects who test negative for this marker. We have studied a substantially larger series of at-risk subjects who have been thoroughly screened for the absence of neurologic or psychiatric features of Huntington's disease and have undergone predictive DNA testing. No evidence of cognitive or emotional differences between markerpositive and marker-negative individuals was found. Consideration of the designs and findings of the two studies indicates that it is premature to conclude that there are neuropsychologic impairments in Huntington's disease that precede the clinical onset of the illness.

AB - It has recently been reported that persons at risk for Huntington's disease who test positive for the linked restriction fragment length polymorphism on chromosome 4 display neuropsychologic impairments when compared with at-risk subjects who test negative for this marker. We have studied a substantially larger series of at-risk subjects who have been thoroughly screened for the absence of neurologic or psychiatric features of Huntington's disease and have undergone predictive DNA testing. No evidence of cognitive or emotional differences between markerpositive and marker-negative individuals was found. Consideration of the designs and findings of the two studies indicates that it is premature to conclude that there are neuropsychologic impairments in Huntington's disease that precede the clinical onset of the illness.

UR - http://www.scopus.com/inward/record.url?scp=0025128079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025128079&partnerID=8YFLogxK

U2 - 10.1001/archneur.1990.00530080093016

DO - 10.1001/archneur.1990.00530080093016

M3 - Article

VL - 47

SP - 905

EP - 908

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 8

ER -